Current Physician's Perception of Proton Pump Inhibitor-related Adverse Effects

Current Physician's Perception of Proton Pump Inhibitor-related Adverse Effects

Saved in:

Bibliographic Details
Main Author:	Cheol Woong Choi
Format:	Article
Language:	English
Published:	Korean College of Helicobacter and Upper Gastrointestinal Research 2021-03-01
Series:	The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Online Access:	http://www.helicojournal.org/upload/pdf/kjhugr-2020-0034.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety of proton pump inhibitors
by: Ye. A. Losik
Published: (2016-08-01)

Current management of proton pump inhibitor-refractory gastroesophageal reflux disease
by: V. V. Tsukanov, et al.
Published: (2020-06-01)

Proton pump inhibitors in pediatric practice
by: Anna A. Shilova, et al.
Published: (2023-11-01)

RENAL SAFETY OF PROTON PUMP INHIBITORS
by: A. I. Dyadyk, et al.
Published: (2017-12-01)

Six stabs in the back of proton pump inhibitors
by: Andrei Evgenyevich Karateev
Published: (2013-06-01)

Proton Pump Inhibitors in the COVID-19 Pandemic
by: T. E. Kugler, et al.
Published: (2022-08-01)

Can Proton Pump Inhibitors Affect Eradication Therapy?
by: Sung Eun Kim
Published: (2020-09-01)

Is a proton pump inhibitor (PPI) the GP's gastroscopy?
by: H.R. Schneider
Published: (2005-03-01)

Gastroesophageal reflux disease, resistant to proton pump inhibitors
by: V. O. Kaybysheva, et al.
Published: (2011-06-01)

Proton pump inhibitors and all-cause mortality in colorectal cancer
by: Arunkumar Krishnan, et al.
Published: (2025-07-01)

Risk of Bacterial Infection from Proton Pump Inhibitor Use
by: Sung Soo Kim, et al.
Published: (2017-06-01)

Hip Fracture and Proton Pump Inhibitor Therapy: Position Statement
by: Paul Moayyedi
Published: (2008-01-01)

Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting system
by: Bowen Wang, et al.
Published: (2025-01-01)

Pharmacodynamics, pharmacokinetics, interactions with other drugs, toxicity and clinical effectiveness of proton pump inhibitors
by: Łukasz Wołowiec, et al.
Published: (2025-07-01)

Proton-pump Inhibitors and the Risk of Dementia: A Systematic Review and Meta-analysis
by: Kyu-Tae Yoon, et al.
Published: (2021-06-01)

IMMEDIATE AND DELAYED HYPERSENSITIVITY REACTIONS TO PROTON PUMP INHIBITORS: A REVIEW ARTICLE
by: Corovic Vahida, et al.
Published: (2025-05-01)

Clinical Significance of Changes in Gut Microbiome Associated with Use of Proton Pump Inhibitors
by: Tae Jun Kim, et al.
Published: (2020-09-01)

New opinion on the issue of proton pump inhibitor-refractory gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2014-11-01)

Comparison of clinical and pharmacodynamic features of proton pump inhibitors efficacy in gastroesophageal reflux disease
by: O. A. Storonova, et al.
Published: (2015-12-01)

How to Make the Right Choice of Proton Pump Inhibitor for Patients with Gastroesophageal Reflux Disease?
by: Yu. V. Evsyutina
Published: (2023-06-01)

Prevention of gastrointestinal bleeding in patients receiving oral anticoagulants: focus on proton pump inhibitors
by: O. D. Ostroumova, et al.
Published: (2019-11-01)

СONCOMITANT ADMINISTRATION OF CLOPIDOGREL AND PROTON PUMP INHIBITORS: ARE THERE ANY OPEN QUESTIONS LEFT TODAY?
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

Association Between Proton Pump Inhibitor Use and Spontaneous Bacterial Peritonitis in Cirrhotic Patients with Ascites
by: Mélissa Ratelle, et al.
Published: (2014-01-01)

EARLY PARENTERAL USE OF PROTON PUMP INHIBITORS IN THE COMPLEx TREATMENT OF ACUTE POISONING WITH CAUTERANT AGENTS
by: K. K. Ilyashenko, et al.
Published: (2016-03-01)

Peptic Ulcer-related Stenosis
by: Cheol Woong Choi
Published: (2019-03-01)

ESTIMATION OF CLINICAL AND PHARMACOECONOMIC EFFICIENCY OF PROTON PUMP INHIBITORS DURING GASTROESOPHAGEAL REFLUX DISEASE (GERD) TREATMENT
by: N. E. Shabanova, et al.
Published: (2018-12-01)

Study of the Effect of Proton Pump Inhibitors on the Development of Hypomagnesemia in Patients with Paroxysmal Atrial Fibrillation on the Background of Autonomic Sinus Node Dysfunction
by: Ya. G. Bozhko, et al.
Published: (2020-01-01)

Step-Down Therapy Using Vonoprazan for Giant Gastric Polyps in Long-Term Proton Pump Inhibitor Administration
by: Daisuke Kikuchi, et al.
Published: (2025-03-01)

Gastroesophageal reflux disease in a comorbid patient, refractory to proton pump inhibitors. How can we help?
by: I. G. Pakhomova
Published: (2024-11-01)

Vonoprazan Versus Intravenous Proton Pump Inhibitor for Prevention of High-Risk Peptic Ulcers Rebleeding After Endoscopic Hemostasis
by: Jin Lee
Published: (2024-09-01)

Long-term proton pump inhibitors therapy and prevalence of hyperprolactinemia. a cross-sectional study in outpatient gastroenterology clinics
by: Muhammad Ashfaq, et al.
Published: (2024-05-01)

Helicobacter pylori infection at long-term treatment by proton pump inhibitors for acid-related diseases (Literature review and resolution of Advisory council, March 22, 2018)
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Improving Proton-Pump Inhibitor Adherence Intervention Between Primary Care and Community Pharmacies: A Pre-Post Intervention Study
by: Puig-Moltó M, et al.
Published: (2024-12-01)

The Effect of Combined Therapy with a Proton Pump Inhibitor and Rebamipide on the Clinical Course and Morphofunctional Changes of the Esophageal Mucosa in Patients with Non-Erosive Reflux Disease
by: A. A. Makushina, et al.
Published: (2025-06-01)

Proton pump inhibitors use and risk of type 2 diabetes mellitus: correlation analysis, prediction model construction, and key genes identification
by: Cuilv Liang, et al.
Published: (2025-04-01)

Features of the Parameters of 24-Hours pH-Impedance and High-Resolution Esophageal Manometry in Patients with Barrett's Esophagus on Proton Pump Inhibitors
by: I. V. Maev, et al.
Published: (2023-06-01)

Specificity and tunability of efflux pumps: A new role for the proton gradient?
by: Matthew Gerry, et al.
Published: (2025-01-01)

Adverse Effects of COX-2 Inhibitors
by: Jagdish N. Sharma, et al.
Published: (2005-01-01)

Effectiveness of a formulary system on prophylactic oral proton pump inhibitors for drug-induced peptic ulcer in a Japanese tertiary hospital: an interrupted time series analysis
by: Ryo Ishida, et al.
Published: (2025-06-01)

Weak Acids as Endogenous Inhibitors of the Proton-Activated Chloride Channel
by: Inês C. A. Pombeiro Stein, et al.
Published: (2025-07-01)